Results 121 to 130 of about 25,455 (216)
Nalfurafine hydrochloride to treat pruritus: a review
Shigeki InuiDepartment of Regenerative Dermatology, Osaka University Graduate School of Medicine, Osaka, JapanAbstract: Uremic pruritus has a great negative influence on quality of life in hemodialysis (HD) patients and, importantly, negatively affects ...
Inui S
doaj
Baowen Liu, Yi Liu, Ningbo Li, Jin Zhang, Xianwei Zhang Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Background: Oxycodone, which is one of the most commonly used ...
Liu BW, Liu Y, Li NB, Zhang J, Zhang XW
doaj
A Background of the Opioid Epidemic and Its Relationship to the Medicaid Expansion [PDF]
Despite the recent increase in public awareness of the opioid epidemic, the background of this epidemic is still disappointingly unknown to the public.
Jang, Er Yearn
core +2 more sources
Buprenorphine in Neonatal Abstinence Syndrome. [PDF]
Infants exposed in utero to opioids will demonstrate a withdrawal syndrome known as neonatal abstinence syndrome (NAS). Buprenorphine is a long-acting opioid with therapeutic use in medication-assisted treatment of opioid dependency in adults and ...
Kraft, Walter K.
core +1 more source
Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
Naltrexone (NTX), a homolog of the opiate antidote naloxone, is an orally active long-acting general opioid receptor antagonist used in the treatment of opiate dependence.
Sho Oasa +8 more
doaj +1 more source
Nalmefene Hydrochloride: Potential Implications for Treating Alcohol and Opioid Use Disorder
MeShell Green,1 Charles A Veltri,1 Oliver Grundmann1,2 1College of Pharmacy, Department of Pharmaceutical Sciences, Midwestern University, Glendale, AZ, USA; 2College of Pharmacy, Department of Medicinal Chemistry, University of Florida, Gainesville, FL,
Green M, Veltri CA, Grundmann O
doaj
Intracellular calcium release activates carotid body afferents by fentanyl. [PDF]
Peng YJ +5 more
europepmc +1 more source
Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease. [PDF]
Elshaikh RH +5 more
europepmc +1 more source
Kappa opioid receptor control of motivated behavior revisited. [PDF]
Farahbakhsh ZZ, Siciliano CA.
europepmc +1 more source

